Karuna Therapeutics logo

Karuna Therapeutics

Karuna Therapeutics is a schizophrenia treatment founded in 2009 by Andrew Miller.

3

Funding Rounds

$148.0m

Money raised

Overview

Karuna Therapeutics is a schizophrenia treatment founded in 2009 by Andrew Miller.

Funding series

Funding Series Analysis

The company Karuna Therapeutics has raised a total of $80m in funding over 3 rounds.

Key Insights:

  • Karuna Therapeutics , April 2019: $12m
  • Karuna Therapeutics Series B round, March 2019: $68m
  • Karuna Therapeutics Inc funding round, March 2019: $68m
Karuna Therapeutics logo
Karuna Therapeutics , April 2019 $12m
Karuna Therapeutics logo
Karuna Therapeutics Series B round, March 2019 $68m
Karuna Therapeutics logo
Karuna Therapeutics Inc funding round, March 2019 $68m

Industries

Karuna Therapeutics is active in the following industries:
  • Engineering
  • Therapeutics
  • Biomedical engineering
  • Life science
  • Technology
  • Biology
  • Biotechnology
  • Healthcare
  • Medicine
  • Neurobiology